244 related articles for article (PubMed ID: 32793278)
1. Plasma Small Extracellular Vesicles Derived miR-21-5p and miR-92a-3p as Potential Biomarkers for Hepatocellular Carcinoma Screening.
Sorop A; Iacob R; Iacob S; Constantinescu D; Chitoiu L; Fertig TE; Dinischiotu A; Chivu-Economescu M; Bacalbasa N; Savu L; Gheorghe L; Dima S; Popescu I
Front Genet; 2020; 11():712. PubMed ID: 32793278
[TBL] [Abstract][Full Text] [Related]
2. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
3. Serum exosomal microRNA-370-3p and microRNA-196a-5p are potential biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Wei Y; Zhang Q; An L; Fang G; Hong D; Jiao T; Yang H; Wang Z
Folia Histochem Cytobiol; 2022; 60(3):215-225. PubMed ID: 35762276
[TBL] [Abstract][Full Text] [Related]
4. Exosomal microRNA-4661-5p-based serum panel as a potential diagnostic biomarker for early-stage hepatocellular carcinoma.
Cho HJ; Baek GO; Seo CW; Ahn HR; Sung S; Son JA; Kim SS; Cho SW; Jang JW; Nam SW; Cheong JY; Eun JW
Cancer Med; 2020 Aug; 9(15):5459-5472. PubMed ID: 32537885
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Derived from Circulating Exosomes as Noninvasive Biomarkers for Diagnosing Renal Cell Carcinoma.
Xiao CT; Lai WJ; Zhu WA; Wang H
Onco Targets Ther; 2020; 13():10765-10774. PubMed ID: 33122915
[TBL] [Abstract][Full Text] [Related]
6. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
7. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
[TBL] [Abstract][Full Text] [Related]
8. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
9. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
[TBL] [Abstract][Full Text] [Related]
10. Exosome Marker Proteins of Tumor-Associated Fibroblasts and Exosome-Derived miR-92a-3p Act as Potential Biomarkers for Liver Cancer.
Liu X; Cheng D; Cui M; Qu F; Yu J; Tang Z; Wang L
Crit Rev Eukaryot Gene Expr; 2022; 32(1):49-57. PubMed ID: 35377980
[TBL] [Abstract][Full Text] [Related]
11. Using Next-generation Sequencing to Identify Novel Exosomal miRNAs as Biomarkers for Significant Hepatic Fibrosis.
Wang Q; Hu Q; Ying Y; Lu C; Li W; Huang C; Xu W; Li Q; Qi X; Zhang X; Liu X; Du Z; Feng Y; Zhang Y; Li X; Ji Y; Zhang J; Wang J; Chen L; Huang Y
Discov Med; 2021; 31(164):147-159. PubMed ID: 35188889
[TBL] [Abstract][Full Text] [Related]
12. Circulating serum exosomal
Lu X; Lu J; Wang S; Zhang Y; Ding Y; Shen X; Jing R; Ju S; Chen H; Cong H
Future Oncol; 2021 Mar; 17(8):907-919. PubMed ID: 33533649
[TBL] [Abstract][Full Text] [Related]
13. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
[TBL] [Abstract][Full Text] [Related]
14. Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles.
Liu Y; Li Q; Hosen MR; Zietzer A; Flender A; Levermann P; Schmitz T; Frühwald D; Goody P; Nickenig G; Werner N; Jansen F
Circ Res; 2019 Feb; 124(4):575-587. PubMed ID: 30582459
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
16. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
[TBL] [Abstract][Full Text] [Related]
17. Plasma-derived exosomal let-7c-5p, miR-335-3p, and miR-652-3p as potential diagnostic biomarkers for stable coronary artery disease.
Han J; Cui X; Yuan T; Yang Z; Liu Y; Ren Y; Wu C; Bian Y
Front Physiol; 2023; 14():1161612. PubMed ID: 37228823
[No Abstract] [Full Text] [Related]
18. Subpopulations of exosomes purified via different exosomal markers carry different microRNA contents.
Wu SC; Kuo PJ; Rau CS; Wu YC; Wu CJ; Lu TH; Lin CW; Tsai CW; Hsieh CH
Int J Med Sci; 2021; 18(4):1058-1066. PubMed ID: 33456364
[TBL] [Abstract][Full Text] [Related]
19. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
Zhang C; Xia R; Zhang B; Wang H
BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
[TBL] [Abstract][Full Text] [Related]
20. Baseline Expression of Exosomal miR-92a-3p and miR-221-3p Could Predict the Response to First-Line Chemotherapy and Survival in Metastatic Colorectal Cancer.
Gherman A; Balacescu L; Popa C; Cainap C; Vlad C; Cainap SS; Balacescu O
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
